The plant-based food market sees a demand surge as consumers seek out new and novel products. Producers are partnering with firms like CRB to design and build research and production facilities that will adapt and grow as the segment’s products evolve.
CRB is proud to announce that the Amicus Therapeutics Research and Gene Therapy Center facility has won Engineering News-Record (ENR) MidAtlantic’s 2020 Best Projects (Award of Merit) in the Healthcare category.
Tom Rychlewski leverages CRB’s expertise for companies considering entry into the plant-based protein segment in Food Engineering‘s “Plant-based protein market offers potential for product, processing innovation.”
Mark Paskanik, AIA, NCARB will lead a webinar on “Innovative Science with Less and the Lab Future” at the Lab Design Digital Summit. Taking place May 11-13, this digital summit will feature a series of informative webinars that will bring together lab management leaders with experts in the laboratory and healthcare design community.
As the food and beverage market shifts to a new way of working amid COVID-19, manufacturers remain hopeful for 2020. Jason Robertson joins Food Processing to recap industry figures for 2019 and share forward-facing food and forward-facing challenges in “2020 Capital Spending Outlook: Getting to Yes on Capital Projects.”
Vaccines and therapies can’t come soon enough for a world desperate to limit or erase the threat of COVID-19. But there’s good news from an industry long accustomed to a speed-to-market mentality: Pharmaceutical companies are fully engaged.
CRB is a proud sponsor of the 2020 ISPE Aseptic Conference which will focus on providing flexible and reliable solutions for the implementation and management of the latest in aseptic, barrier, containment, and aseptic best practice technologies, including automated visual inspections.
Allan Bream, Bioprocess Specialist at CRB, was recently featured in Pharma’s Almanac, with an article entitled, “Isolator Design in Cell Therapy Facilities.”
Cell and gene therapy manufacturing must be performed under aseptic conditions and with good aseptic handling practices to ensure patient safety. The use of isolators can help address this critical need, but designing isolators for advanced therapy medicinal product (ATMP) processes can be challenging.
Noel Maestre, PE and Emily Thompson, PE will be conducting a webinar via Cell and Gene Therapy Insights on how to deliver multi-product or multi-modal Advanced Therapy Medicinal Product (ATMP) facilities to adapt to an evolving product pipeline.
Supporting our recent project growth in southern California, CRB is pleased to announce we’ve opened a new office in Tustin, Calif. The location will allow us to attract the best talent in the southern California region, pursue new business in Orange County and assist new and ongoing projects affiliated with its office in El Segundo, Calif.
CRB’s David B. Korzuch Jr., PE; and Christopher J. Barbieri, PE detailed several energy-saving strategies that can be implemented into the HVAC system design of a pharmaceutical-grade clean room suite in Consulting Specifying Engineer (CSE).
CRB is proud to sponsor the 2020 ISPE Facilities of the Future Conference which will explore advancements in pharmaceutical technology and what pharmaceutical manufacturing facilities will look like in the future. Featuring technical and inspirational presentations from industry leaders already planning and building “facilities of the future” this conference will look at new manufacturing challenges, technologies, and regulatory factors impacting the ability of today’s companies to stay competitive and cost-effective.
Philip Lyman, PhD and Peter Walters will be speaking at Phacilitate Leaders World & World Stem Cell Summit 2020! Taking place January 21 – 24, 2020 in Miami, this event will bring together the entire ecosystem of the advanced therapies industry from all corners of the globe.
CRB is often called upon by our clients to uncover energy savings. In the November issue of Food Engineering, Jeremy Gualdoni explains an energy recovery strategy used for a confectionery client in “Solving the Energy Equation.”
Peter Walters’ “The Pain-Free Guide: Transitioning from Clinical Production to Commercial Manufacturing” was featured in Contract Pharma. The article describes how cell and gene therapy facilities face a unique set of challenges as they scale towards commercial production and require equally unique solutions.
Autodesk University, a learning community that connects many of today’s design and engineering experts from industries across architecture and construction, manufacturing, media and entertainment, will be held at the Sands Convention Center in Las Vegas, Nevada, November 18-21, 2019.
ISPE’s Company of the Year award honors a company that continually supports the society’s commitment to providing knowledge and best practices that help meet the technical challenges of the pharmaceutical manufacturing industry.
Stop by the CRB booth at ISPE’s Annual Meeting to meet our team and learn how we’re leveraging the latest technologies to design and build some of the most powerful facilities in the world—those that change people’s lives.
The International Institute for Sustainable Laboratories (I²SL) Annual Conference is the leading international conference focused on strategies to meet the challenges of energy efficiency and environmental sustainability in laboratories and related facilities. The conference is a technical forum where information is exchanged covering the life cycle of the laboratory from design to use.
Chelsea Stramel, Architectural Designer and Jake Adams, Process Engineer were featured in Contract Pharma’s “Designing a Successful Oligonucleotide Facility – Five questions you probably aren’t asking, but should.”
David Keith, Director of Strategic Facility Planning, and Debora Hankinson, Senior Strategic Facility Planner will teach a pre-conference course titled “Fundamentals of Space Planning and Space Management” at Tradeline Space Strategies 2019 in San Diego, California.
CRB is excited to announce that Can Aktar has been appointed the leader of the Basel office and Christian Goesker has joined as engineering, procurement and construction management (EPCM) director in Stuttgart.
What if you could see your manufacturing potential and determine your cell and gene therapy strategy before making a large capital investment? Whether it’s a unit operation, single process train or entire manufacturing plant, new technologies allow companies to study and validate potential processes earlier than ever before.
Niranjan Kulkarni, Grace Linton and Allan Bream were interviewed in Cell and Gene Therapy Insights on “How commercial biopharma experience is shaping cell and gene therapy facility design.” The interview will give you some intel to how facility design differs from other sectors and what unique parameters need to be accounted for before embarking on a new facility.